Subscribe To
Los andes copper says new drill results from vizcachitas point to the project's large-scale copper potential
Los Andes Copper Ltd (TSX-V:LA) reported more positive results from its initial drill program at the Vizcac...
June 22, 2022, 1:08 pm
Why novavax stock jumped today
Novavax did a few encore presentations of its coronavirus vaccine efficacy and safety data at a confere...
June 22, 2022, 12:21 pm
Zynerba pharmaceuticals reports positive results from phase 2 trial of zygel cbd gel in 22q11.2 deletion syndrome
Zynerba Pharmaceuticals (NASDAQ:ZYNE) Inc has announced “very encouraging” data from a trial of its Zygel CBD gel for the treatment of 22q11.2 Del...
June 22, 2022, 8:01 am
Aftermath silver agrees to sell cachinal de la sierra silver-gold project in chile to honey badger silver
Aftermath Silver (TSX-V:AAG) Ltd said it has entered a non-binding term sheet to sell its 100% interest in the ...
June 13, 2022, 7:15 am
Vigna to set out ferrari's route into electric vehicle era
Nine months after taking the top job, Ferrari CEO Benedetto Vigna will be expected this week to explain how the carmaker will preserve its ...
June 13, 2022, 5:08 am
Gsk seeks approval for respiratory vaccine after trials show 'meaningful efficacy'
GlaxoSmithKline PLC (LSE:GSK) said it engaged regulators to submit a new respiratory virus vaccine for approval before the end of the year. The ph...
June 10, 2022, 3:09 am
Rigel (rigl) waiha study fails to meet goals, stock tanks
Rigel (RIGL) phase III study evaluating fostamatinib in patients with warm autoimmune hemolytic anemia did not demonstrate statistical significance in...
June 9, 2022, 2:17 pm
Revive therapeutics submits data access plan for bucillamine in coronavirus clinical trial to fda
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) has updated further on its Phase 3 clinical trial for Bucillamine in coronavirus (COVID-19), saying it ...
June 6, 2022, 2:43 pm
Abbvie's failure solidifies vertex pharmaceuticals' cystic fibrosis leadership position
Vertex's competitor AbbVie said its triple combination did not achieve the efficacy threshold to push t...
June 6, 2022, 11:37 am
Gevo enters into partner agreement with google cloud to measure and verify the efficacy of next-generation biofuels; launches $150m registered direct offering
Gevo Inc (NASDAQ:GEVO) said it has entered into a partner agreement with Google Cloud to measure and verify the effi...
June 6, 2022, 8:26 am
Pliant: major catalyst expected beginning of 2023
Results from the phase 2a INTEGRIS-PSC study using PLN-74809 for the treatment of patients with primary sclerosing cholangitis are expected 1st half o...
June 3, 2022, 6:26 pm
New york lawmakers pass bill limiting amazon's use of worker productivity quotas in warehouses
Amazon employees and worker advocacy groups have argued that Amazon's focus on speed has led to an incr...
June 3, 2022, 5:53 pm
Musk's twitter deal faces backlash from advocacy groups that are seeking to block it
Accountable Tech, Center for Countering Digital Hate, GLAAD and other nonprofits warn Musk will degrade safeguards on Twitter if he buys the company....
June 3, 2022, 9:00 am
Here is why springworks therapeutics jumped 20%
SpringWorks Therapeutics Inc. (NASDAQ: SWTX) stock jumped 20% after the clinical-stage company focusing on life-changing treatment for cancer, and rar...
May 27, 2022, 4:13 pm
Why is caci international (caci) up 3.8% since last earnings report?
cacI International (cacI) reported earnings 30 days ago....
May 27, 2022, 12:48 pm
Karyopharm to present new selinexor data at the 2022 american society of clinical oncology annual meeting
– Encouraging Initial Data Observed in Phase 1/2 Study of Selinexor in Combination with Ruxolitinib in Treatment-Naïve Myelofibrosis, Including Fav...
May 26, 2022, 5:08 pm
Elevation oncology to present initial seribantumab proof-of-concept data from phase 2 crestone study in patients with tumors harboring nrg1 fusions at asco 2022
Positive initial data support the potential of seribantumab to induce deep and durable benefit for patients with tumors harboring NRG1 fusions Clinica...
May 26, 2022, 5:05 pm
Jushi holdings inc. (jushf) ceo james cacioppo on q1 2022 results - earnings call transcript
Jushi Holdings Inc. (OTCQX:JUSHF) Q1 2022 Earnings Conference Call May 25, 2022 9:00 AM ET Company Participants Michael Perlman - Executive Vice Presi...
May 25, 2022, 5:17 pm
Veru inc. still has serious growth to realize
Veru Inc is a Florida-based drug developer, which focuses primarily on developing cancer-treatment drugs as well as its sexual health division. This y...
May 19, 2022, 3:41 am
Alteryx, inc. (ayx) ceo mark anderson hosts 2022 alteryx investors session conference (transcript)
Alteryx, Inc. (NYSE:AYX ) 2022 Alteryx Investors Session Conference Call May 17, 2022 3:00 PM ET Company Participants Ryan Goodman - Vice President, I...
May 18, 2022, 2:08 am